BioCardia

BioCardia is a clinical-stage regenerative medicine company developing novel therapies for cardiovascular diseases. BioCardia's primary therapeutic candidate is the CardiAMP Cell Therapy System, which is used to treat heart failure and chronic myocardial ischemia. The company is also developing the CardiALLO Cell Therapy System, an investigational cultured expanded bone marrow derived from mesenchymal cell therapy currently in Phase I/II trials for the treatment of ischemic systolic heart failure.